<http://webisa.webdatacommons.org/49893083>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/49893083>	<http://www.w3.org/ns/prov#value>	"According to yet another embodiment, the present invention relates to an immunotoxin or a composition comprising the same as defined above for use in a method for preventing or treating autoimmune diseases such as rheumatoid arthritis and systematic lupus erythematosus in a patient, the method comprising administering to a patient in need of such treatment a therapeutically effective amount of an" .
<http://webisa.webdatacommons.org/49893083>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.com.au> .
<http://webisa.webdatacommons.org/prov/24040627>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/49893083> .
<http://webisa.webdatacommons.org/prov/477898009>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/49893083> .